Bella S. Guerrouahen
Doha, DA, Qatar
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
NCI 10211: a phase II, single-arm study of berzosertib in combination with irinotecan in patients with advanced TP53 mutant gastroesophageal cancer.
Journal: The oncologist
Published: August 06, 2025
Exercise Promotes Pro-Apoptotic Ceramide Signaling in a Mouse Melanoma Model.
Journal: Cancers
Published: August 15, 2022
Proceedings From the First International Workshop at Sidra Medicine: "Engineered Immune Cells in Cancer Immunotherapy (EICCI): From Discovery to Off-the-Shelf Development", 15th-16th February 2019, Doha, Qatar.
Journal: Frontiers in immunology
Published: July 30, 2020
Reverting Immune Suppression to Enhance Cancer Immunotherapy.
Journal: Frontiers in oncology
Published: September 04, 2019
Blockade of TGF-β signaling to enhance the antitumor response is accompanied by dysregulation of the functional activity of CD4+CD25+Foxp3+ and CD4+CD25-Foxp3+ T cells.
Journal: Journal of translational medicine
Published: March 18, 2019
Enhancing Mesenchymal Stromal Cell Immunomodulation for Treating Conditions Influenced by the Immune System.
Journal: Stem cells international
Published: January 31, 2019
Tailoring cells for clinical needs: Meeting report from the Advanced Therapy in Healthcare symposium (October 28-29 2017, Doha, Qatar).
Journal: Journal of translational medicine
Published: August 28, 2018
Nesting of colon and ovarian cancer cells in the endothelial niche is associated with alterations in glycan and lipid metabolism.
Journal: Scientific reports
Published: September 28, 2016
Metabolic signatures differentiate ovarian from colon cancer cell lines.
Journal: Journal of translational medicine
Published: January 13, 2015
Last Updated: 09/26/2026